155 related articles for article (PubMed ID: 38792889)
21. Overview on the management of non-gastric MALT lymphomas.
Defrancesco I; Arcaini L
Best Pract Res Clin Haematol; 2018 Mar; 31(1):57-64. PubMed ID: 29452667
[TBL] [Abstract][Full Text] [Related]
22. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
23. Extranodal marginal zone B-cell lymphoma of the gastrointestinal tract sparing only the esophagus: a case report.
Lin CC; Lai HW; Tsai MC; Chen TH; Tseng SW; Chang H; Chen TY
Turk J Gastroenterol; 2012 Feb; 23(1):58-62. PubMed ID: 22505381
[TBL] [Abstract][Full Text] [Related]
24. Bendamustine-rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patients.
Morigi A; Argnani L; Lolli G; Broccoli A; Pellegrini C; Nanni L; Stefoni V; Coppola PE; Carella M; Casadei B; Sabattini E; Cavo M; Zinzani PL
Hematol Oncol; 2020 Oct; 38(4):487-492. PubMed ID: 32594531
[TBL] [Abstract][Full Text] [Related]
25. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature.
Ely A; Evans J; Sundstrom JM; Malysz J; Specht CS; Wilkinson M
Orbit; 2012 Aug; 31(4):267-9. PubMed ID: 22681504
[TBL] [Abstract][Full Text] [Related]
26. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
[TBL] [Abstract][Full Text] [Related]
27. Mucosa-associated lymphoid tissue lymphoma with unusual
Zhang NS; Shi F; Kong L; Zhu H
World J Gastroenterol; 2017 Jan; 23(3):551-559. PubMed ID: 28210093
[TBL] [Abstract][Full Text] [Related]
28. Mucosa-associated lymphoid tissue lymphoma with intraocular and orbital involvement: case presentation and review of the literature.
Freedman K; Shenoy S
Orbit; 2018 Aug; 37(4):243-247. PubMed ID: 29027822
[TBL] [Abstract][Full Text] [Related]
29. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
30. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
31. Sequential development of multifocal recurrent non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue and diffuse large B-Cell lymphoma in a single patient: A case report.
Yang X; Min X; He W
Medicine (Baltimore); 2018 May; 97(21):e10845. PubMed ID: 29794780
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin VH gene expression among extranodal marginal zone B-cell lymphomas of the ocular adnexa.
Coupland SE; Foss HD; Anagnostopoulos I; Hummel M; Stein H
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):555-62. PubMed ID: 10067957
[TBL] [Abstract][Full Text] [Related]
33. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.
Rosado MF; Byrne GE; Ding F; Fields KA; Ruiz P; Dubovy SR; Walker GR; Markoe A; Lossos IS
Blood; 2006 Jan; 107(2):467-72. PubMed ID: 16166588
[TBL] [Abstract][Full Text] [Related]
34. Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma.
Kim KM; Kim HC; Jeon KN; Kim HG; Kang JH; Hahm JR; Lee GW
Yonsei Med J; 2008 Feb; 49(1):155-8. PubMed ID: 18306483
[TBL] [Abstract][Full Text] [Related]
35. Ophthalmologic outcomes after chemotherapy and/or radiotherapy in non-conjunctival ocular adnexal MALT lymphoma.
Paik JS; Cho WK; Lee SE; Choi BO; Jung SE; Park GS; Kim SH; Yang SW; Cho SG
Ann Hematol; 2012 Sep; 91(9):1393-401. PubMed ID: 22543827
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
37. Extraocular muscle involvement in marginal zone B-cell lymphomas of the orbit.
Izambart C; Robert PY; Petellat F; Petit B; Gastaud P; Lagier J; Labrousse F; Adenis JP
Orbit; 2008; 27(5):345-9. PubMed ID: 18836931
[TBL] [Abstract][Full Text] [Related]
38. Favourable response to rituximab by an ocular adnexal primary lymphoma.
Luque Valentin-Fernandez ML; Alvarez Rodríguez F; Rodríguez Jiménez I
Arch Soc Esp Oftalmol; 2016 Nov; 91(11):539-542. PubMed ID: 27125186
[TBL] [Abstract][Full Text] [Related]
39. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type.
White WL; Ferry JA; Harris NL; Grove AS
Ophthalmology; 1995 Dec; 102(12):1994-2006. PubMed ID: 9098307
[TBL] [Abstract][Full Text] [Related]
40. Intrapericardial and intrapleural administration of rituximab to a patient with marginal zone lymphoma.
Boguradzki P; Drozd-Sokolowska JE; Wieczorek J; Kowalik R; Starczewska M; Krol M; Kobylecka M; Opolski G; Wiktor-Jedrzejczak W
Acta Haematol; 2013; 130(3):169-71. PubMed ID: 23735747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
